🟢 West Pharmaceutical Services is trading 6.5% up in pre-market after third-quarter beat and raised full-year guidance

West Pharmaceutical Services is trading at $430.00, +6.53%, in pre-market after its third-quarter earnings beat and raised full-year guidance.

• On October 29, 2026, the company reported third-quarter sales of $874.5 million and adjusted EPS of $2.66, both ahead of estimates.
• It raised full-year sales guidance to $3.41–$3.42 billion and adjusted EPS guidance to $9.38–$9.48.
• Strong biologics-related Proprietary Products growth supported the outlook.